Associations between dietary acrylamide intake and plasma sex hormone levels

Cancer Epidemiology Biomarkers and Prevention

Volumn 22, Issue 11, 2013, Pages 2024-2036

  Hogervorst, Janneke G ^a   Fortner, Renee T ^b,c   Mucci, Lorelei A ^b,c   Tworoger, Shelley S ^b,c   Eliassen, A Heather ^b,c   Hankinson, Susan E ^b,c,d   Wilson, Kathryn M ^b,c  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACRYLAMIDE; ANDROGEN; BIOLOGICAL MARKER; ESTRONE SULFATE; PROLACTIN; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; BREAST CANCER; CANCER RISK; DIETARY INTAKE; ESTRADIOL BLOOD LEVEL; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; HORMONE BLOOD LEVEL; HUMAN; OBESITY; OVARY CANCER; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; TESTOSTERONE BLOOD LEVEL;

ACRYLAMIDE; ADULT; CARCINOGENS; CROSS-SECTIONAL STUDIES; DIET; FEMALE; GONADAL STEROID HORMONES; HUMANS; MIDDLE AGED; RISK FACTORS;

EID: 84887293657     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-13-0509     Document Type: Article

References (81)

1. International Agency for Research on Cancer. Some industrial chemicals- IARC Monographs on the evaluation of carcinogenic risks to humans, vol. 60. Lyon, France: International Agency for Research on Cancer; 1994.
2. Konings EJ, Baars AJ, van Klaveren JD, Spanjer MC, Rensen PM, Hiemstra M, et al. Acrylamide exposure from foods of the Dutch population and an assessment of the consequent risks. Food Chem Toxicol 2003;41:1569-79.
3. Matthys C, Bilau M, Govaert Y, Moons E, De Henauw S, Willems JL. Risk assessment of dietary acrylamide intake in Flemish adolescents. Food Chem Toxicol 2005;43:271-8.
4. Bergmark E. Hemoglobin adducts of acrylamide and acrylonitrile in laboratory workers, smokers, and nonsmokers. Chem Res Toxicol 1997;10:78-84.
5. Schettgen T, Rossbach B, Kutting B, Letzel S, Drexler H, Angerer J. Determination of haemoglobin adducts of acrylamide and glycidamide in smoking and nonsmoking persons of the general population. Int J Hyg Environ Health 2004;207:531-9.
6. Friedman MA, Dulak LH, Stedham MA. A lifetime oncogenicity study in rats with acrylamide. Fundam Appl Toxicol 1995;27: 95-105.
7. Johnson KA, Gorzinski SJ, Bodner KM, Campbell RA, Wolf CH, Friedman MA, et al. Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol 1986;85:154-68.
8. Dourson M, Hertzberg R, Allen B, Haber L, Parker A, Kroner O, et al. Evidence-based dose-response assessment for thyroid tumorigenesis from acrylamide. Regul Toxicol Pharmacol 2008;52:264-89.
9. Haber LT, Maier A, Kroner OL, Kohrman MJ. Evaluation of human relevance and mode of action for tunica vaginalis mesotheliomas resulting from oral exposure to acrylamide. Regul Toxicol Pharmacol 2009;53:134-49.
10. Besaratinia A, Pfeifer GP. A review of mechanisms of acrylamide carcinogenicity. Carcinogenesis 2007;28:519-28.
11. Exon JH. A review of the toxicology of acrylamide. J Toxicol Environ Health B Crit Rev 2006;9:397-412.
12. Klaunig JE, Kamendulis LM. Mechanisms of acrylamide induced rodent carcinogenesis. Adv Exp Med Biol 2005;561:49-62.
13. Segerback D, Calleman CJ, Schroeder JL, Costa LG, Faustman EM. Formation of N-7-(2-carbamoyl-2-hydroxyethyl)guanine in DNA of the mouse and the rat following intraperitoneal administration of [14C]acrylamide. Carcinogenesis 1995;16:1161-5.
14. Ali SF, Hong JS, Wilson WE, Uphouse LL, Bondy SC. Effect of acrylamide on neurotransmitter metabolism and neuropeptide levels in several brain regions and upon circulating hormones. Arch Toxicol 1983;52:35-43.
15. Mannaa F, Abdel-Wahhab MA, Ahmed HH, Park MH. Protective role of Panax ginseng extract standardized with ginsenoside Rg3 against acrylamide-induced neurotoxicity in rats. J Appl Toxicol 2006;26:198-206.
16. Uphouse LL, Nemeroff CB, Mason G, Prange AJ, Bondy SC. Interactions between "handling" and acrylamide on endocrine responses in rats. Neurotoxicology 1982;3:121-5.
17. Clement FC, Dip R, Naegeli H. Expression profile of human cells in culture exposed to glycidamide, a reactive metabolite of the heatinduced food carcinogen acrylamide. Toxicology 2007;240:111-24.
18. Lee T, Manjanatha MG, Aidoo A, Moland CL, Branham WS, Fuscoe JC, et al. Expression analysis of hepatic mitochondria-related genes in mice exposed to acrylamide and glycidamide. J Toxicol Environ Health A 2012;75:324-39.
19. Mei N, Guo L, Tseng J, Dial SL, Liao W, Manjanatha MG. Gene expression changes associated with xenobiotic metabolism pathways in mice exposed to acrylamide. Environ Mol Mutagen 2008;49:741-5.
20. Hogervorst JG, Schouten LJ, Konings EJ, Goldbohm RA, van den Brandt PA. A prospective study of dietary acrylamide intake and the risk of endometrial, ovarian, and breast cancer. Cancer Epidemiol Biomarkers Prev 2007;16:2304-13.
21. Wilson KM, Mucci LA, Rosner BA, Willett WC. A prospective study on dietary acrylamide intake and the risk for breast, endometrial, and ovarian cancers. Cancer Epidemiol Biomarkers Prev 2010;19:2503-15.
22. Larsson SC, Hakansson N, Akesson A, Wolk A. Long-term dietary acrylamide intake and risk of endometrial cancer in a prospective cohort of Swedish women. Int J Cancer 2009;124:1196-9.
23. Larsson SC, Akesson A, Wolk A. Long-term dietary acrylamide intake and risk of epithelial ovarian cancer in a prospective cohort of Swedish women. Cancer Epidemiol Biomarkers Prev 2009;18:994-7.
24. Pelucchi C, Galeone C, Levi F, Negri E, Franceschi S, Talamini R, et al. Dietary acrylamide and human cancer. Int J Cancer 2006;118:467-71.
25. Xie J, Terry KL, Poole EM, Wilson KM, Rosner BA, Willett WC, et al. Acrylamide hemoglobin adduct levels and ovarian cancer risk: A nested case-control study. Cancer Epidemiol Biomarkers Prev 2013; 22:653-60.
26. Larsson SC, Akesson A, Wolk A. Long-term dietary acrylamide intake and breast cancer risk in a prospective cohort of Swedish women. Am J Epidemiol 2009;169:376-81.
27. Mucci LA, Sandin S, Balter K, Adami HO, Magnusson C, Weiderpass E. Acrylamide intake and breast cancer risk in Swedish women. JAMA 2005;293:1326-7.
28. Wilson KM, Mucci LA, Cho E, Hunter DJ, Chen WY, Willett WC. Dietary acrylamide intake and risk of premenopausal breast cancer. Am J Epidemiol 2009;169:954-61.
29. Olesen PT, Olsen A, Frandsen H, Frederiksen K, Overvad K, Tjonneland A. Acrylamide exposure and incidence of breast cancer among postmenopausal women in the Danish Diet, Cancer and Health Study. Int J Cancer 2008;122:2094-100.
30. Pedersen GS, Hogervorst JG, Schouten LJ, Konings EJ, Goldbohm RA, van den Brandt PA. Dietary acrylamide intake and estrogen and progesterone receptor-defined postmenopausal breast cancer risk. Breast Cancer Res Treat 2010;122:199-210.
31. Olsen A, Christensen J, Outzen M, Olesen PT, Frandsen H, Overvad K, et al. Pre-diagnostic acrylamide exposure and survival after breast cancer among postmenopausal Danish women. Toxicology 2012; 296:67-72.
32. Eliassen AH, Hankinson SE. Endogenous hormone levels and risk of breast, endometrial and ovarian cancers: prospective studies. Adv Exp Med Biol 2008;630:148-65.
33. Hankinson SE, Willett WC, Manson JE, Hunter DJ, Colditz GA, Stampfer MJ, et al. Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. J Natl Cancer Inst 1995; 87:1297-302.
34. Tworoger SS, Sluss P, Hankinson SE. Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women. Cancer Res 2006;66:2476-82.
35. Eliassen AH, Chen WY, Spiegelman D, Willett WC, Hunter DJ, Hankinson SE. Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and risk of breast cancer among premenopausal women in the Nurses' Health Study II. Arch Intern Med 2009;169:115-21.
36. Tworoger SS, Lee IM, Buring JE, Hankinson SE. Plasma androgen concentrations and risk of incident ovarian cancer. Am J Epidemiol 2008;167:211-8.
37. Karlson EW, Chibnik LB, McGrath M, Chang SC, Keenan BT, Costenbader KH, et al. A prospective study of androgen levels, hormonerelated genes, and risk of rheumatoid arthritis. Arthritis Res Ther 2009;11:R97.
38. Missmer SA, Spiegelman D, Bertone-Johnson ER, Barbieri RL, Pollak MN, Hankinson SE. Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2- To 3-year period. Cancer Epidemiol Biomarkers Prev 2006;15:972-8.
39. Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst 2004;96:1856-65.
40. Hankinson SE, Willett WC, Michaud DS, Manson JE, Colditz GA, Longcope C, et al. Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst 1999; 91:629-34.
41. Eliassen AH, Missmer SA, Tworoger SS, Spiegelman D, Barbieri RL, Dowsett M, et al. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst 2006;98:1406-15.
42. Tworoger SS, Eliassen AH, Rosner B, Sluss P, Hankinson SE. Plasma prolactin concentrations and risk of postmenopausal breast cancer. Cancer Res 2004;64:6814-9.
43. Fortner RT, Eliassen AH, Spiegelman D, Willett WC, Barbieri RL, Hankinson SE. Premenopausal endogenous steroid hormones and breast cancer risk: results from the Nurses' Health Study II. Breast Cancer Res 2013;15:R19.
44. Sodergard R, BackstromT, Shanbhag V, Carstensen H. Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature. J Steroid Biochem 1982;16:801-10.
45. Willett WC, Sampson L, Stampfer MJ, Rosner B, Bain C, Witschi J, et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 1985;122:51-65.
46. Wilson KM, Vesper HW, Tocco P, Sampson L, Rosen J, Hellenas KE, et al. Validation of a food frequency questionnaire measurement of dietary acrylamide intake using hemoglobin adducts of acrylamide and glycidamide. Cancer Causes Control 2009;20:269-78.
47. Willett WC, Howe GR, Kushi LH. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 1997;65(4 Suppl):1220S-8S.
48. Salvini S, Hunter DJ, Sampson L, Stampfer MJ, Colditz GA, Rosner B, et al. Food-based validation of a dietary questionnaire: The effects of week-to-week variation in food consumption. Int J Epidemiol 1989;18: 858-67.
49. Rosner B. Percentage points for generalized ESD many-outlier procedure. Technometrics 1983;25:165-72.
50. Tworoger SS, Missmer SA, Eliassen AH, Spiegelman D, Folkerd E, Dowsett M, et al. The association of plasma DHEA and DHEA sulfate with breast cancer risk in predominantly premenopausal women. Cancer Epidemiol Biomarkers Prev 2006;15:967-71.
51. Eliassen AH, Missmer SA, Tworoger SS, Hankinson SE. Endogenous steroid hormone concentrations and risk of breast cancer: does the association vary by a woman's predicted breast cancer risk? J Clin Oncol 2006;24:1823-30.
52. Rosner B, Cook N, Portman R, Daniels S, Falkner B. Determination of blood pressure percentiles in normal-weight children: some methodological issues. Am J Epidemiol 2008;167:653-66.
53. Baron JA, La Vecchia C, Levi F. The antiestrogenic effect of cigarette smoking in women. Am J Obstet Gynecol 1990;162:502-14.
54. Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, and endometrial cancer risk: A synthetic review. Cancer Epidemiol Biomarkers Prev 2002;11:1531-43.
55. Tworoger SS, Eliassen AH, Missmer SA, Baer H, Rich-Edwards J, Michels KB, et al. Birthweight and body size throughout life in relation to sex hormones and prolactin concentrations in premenopausal women. Cancer Epidemiol Biomarkers Prev 2006;15:2494-501.
56. Brill MJ, Diepstraten J, van Rongen A, van Kralingen S, van den Anker JN, Knibbe CA. Impact of obesity on drug metabolism and elimination in adults and children. Clin Pharmacokinet 2012;51:277-304.
57. VesperHW, Slimani N, Hallmans G, Tjonneland A, Agudo A, Benetou V, et al. Cross-sectional study on acrylamide hemoglobin adducts in subpopulations from the European Prospective Investigation into Cancer and Nutrition (EPIC) Study. J Agric Food Chem 2008;56:6046-53.
58. Kotsopoulos J, Eliassen AH, Missmer SA, Hankinson SE, Tworoger SS. Relationship between caffeine intake and plasma sex hormone concentrations in premenopausal and postmenopausal women. Cancer 2009;115:2765-74.
59. Persson I. Estrogens in the causation of breast, endometrial, and ovarian cancers-evidence and hypotheses from epidemiological findings. J Steroid Biochem Mol Biol 2000;74:357-64.
60. Salehi F, Dunfield L, Phillips KP, Krewski D, Vanderhyden BC. Risk factors for ovarian cancer: An overview with emphasis on hormonal factors. J Toxicol Environ Health B Crit Rev 2008;11:301-21.
61. Akhmedkhanov A, Zeleniuch-Jacquotte A, Toniolo P.Role of exogenous and endogenous hormones in endometrial cancer: review of the evidence and research perspectives. AnnNY Acad Sci 2001;943:296-315.
62. Allen NE, Key TJ, Dossus L, Rinaldi S, Cust A, Lukanova A, et al. Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer 2008;15:485-97.
63. Risch HA. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst 1998;90:1774-86.
64. Key T, Appleby P, Barnes I, Reeves G. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 2002;94:606-16.
65. Hankinson SE, Eliassen AH. Circulating sex steroids and breast cancer risk in premenopausal women. Horm Cancer 2010;1:2-10.
66. Rinaldi S, Dossus L, Lukanova A, Peeters PH, Allen NE, Key T, et al. Endogenous androgens and risk of epithelial ovarian cancer: results from the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Epidemiol Biomarkers Prev 2007;16:23-9.
67. Helzlsouer KJ, Alberg AJ, Gordon GB, Longcope C, Bush TL, Hoffman SC, et al. Serum gonadotropins and steroid hormones and the development of ovarian cancer. JAMA 1995;274:1926-30.
68. Goodman G, Bercovich D. Prolactin does not cause breast cancer and may prevent it or be therapeutic in some conditions. Med Hypotheses 2008;70:244-51.
69. Lukanova A, Kaaks R. Endogenous hormones and ovarian cancer: epidemiology and current hypotheses. Cancer Epidemiol Biomarkers Prev 2005;14:98-107.
70. Kuhl H, Schneider HP. Progesterone-promoter or inhibitor of breast cancer. Climacteric 2013;16(Suppl 1):54-68.
71. Tworoger SS, Hankinson SE. Prolactin and breast cancer etiology: An epidemiologic perspective. J Mammary Gland Biol Neoplasia 2008; 13:41-53.
72. Levina VV, Nolen B, Su Y, Godwin AK, Fishman D, Liu J, et al. Biological significance of prolactin in gynecologic cancers. Cancer Res 2009;69:5226-33.
73. Janssen I, Heymsfield SB, Allison DB, Kotler DP, Ross R. Body mass index and waist circumference independently contribute to the prediction of nonabdominal, abdominal subcutaneous, and visceral fat. Am J Clin Nutr 2002;75:683-8.
74. Rice S, Patel B, Bano G, Ugwumadu A, Whitehead SA. Aromatase expression in abdominal omental/visceral and subcutaneous fat depots: A comparison of pregnant and obese women. Fertil Steril 2012;97:1460-6.e1.
75. Wake DJ, Strand M, Rask E, Westerbacka J, Livingstone DE, Soderberg S, et al. Intra-adipose sex steroid metabolism and body fat distribution in idiopathic human obesity. Clin Endocrinol 2007;66: 440-6.
76. Bjellaas T, Olesen PT, Frandsen H, Haugen M, Stolen LH, Paulsen JE, et al. Comparison of estimated dietary intake of acrylamide with hemoglobin adducts of acrylamide and glycidamide. Toxicol Sci 2007;98:110-7.
77. Kutting B, Schettgen T, BeckmannMW, Angerer J, Drexler H. Influence of diet on exposure to acrylamide-reflections on the validity of a questionnaire. Ann Nutr Metab 2005;49:173-7.
78. Kutting B, Uter W, Drexler H. The association between self-reported acrylamide intake and hemoglobin adducts as biomarkers of exposure. Cancer Causes Control 2008;19:273-81.
79. Wirfalt E, Paulsson B, Tornqvist M, Axmon A, Hagmar L. Associations between estimated acrylamide intakes, and hemoglobin AA adducts in a sample from the Malmo diet and cancer cohort. Eur J Clin Nutr 2008;62:314-23.
80. Hogervorst JG, Baars BJ, Schouten LJ, Konings EJ, Goldbohm RA, van den Brandt PA. The carcinogenicity of dietary acrylamide intake: A comparative discussion of epidemiological and experimental animal research. Crit Rev Toxicol 2010;40:485-512.
81. Hankinson SE, Manson JE, Spiegelman D, Willett WC, Longcope C, Speizer FE. Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period. Cancer Epidemiol Biomarkers Prev 1995;4:649-54.